Scienture Holdings, Inc. (SCNX) stock
SCNXNasdaqPharmaceutical PreparationsFiscal year ends December 31
$2.90−0.11 (-3.65%)
Close on Nov 13, 2026Market cap $119.09MP/E –Yield –
Scienture operating margin
Operating margin is operating income as a percentage of revenue.
Scienture's operating margin for the twelve months ending Sep 30, 2025 was -2648.5%. For fiscal 2025 it was -9867.9%, against -10758.7% the year before. The highest annual figure on record is 13.5% in fiscal 2017.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -9867.9% | +890.8 |
| FY2024 | Dec 31, 2024 | -10758.7% | −10436.3 |
| FY2023 | Dec 31, 2023 | -322.4% | −293.9 |
| FY2022 | Dec 31, 2022 | -28.4% | +25.1 |
| FY2021 | Dec 31, 2021 | -53.5% | −38.9 |
| FY2020 | Dec 31, 2020 | -14.6% | −16.3 |
| FY2019 | Dec 31, 2019 | 1.7% | +4.0 |
| FY2018 | Dec 31, 2018 | -2.3% | −15.8 |
| FY2017 | Dec 31, 2017 | 13.5% | +54.1 |
| FY2016 | Dec 31, 2016 | -40.6% | −35.9 |
| FY2015 | Dec 31, 2015 | -4.7% | +91.0 |
| FY2014 | Dec 31, 2014 | -95.7% | +122.3 |
| FY2013 | Dec 31, 2013 | -218.0% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -785.6% | +7153.9 |
| Q1 FY2026 | Mar 31, 2026 | -6230.8% | −838.1 |
| Q3 FY2025 | Sep 30, 2025 | -739.1% | +7259.7 |
| Q1 FY2025 | Mar 31, 2025 | -34814.9% | −33063.4 |
| Q4 FY2024 | Dec 31, 2024 | -7939.6% | −7745.4 |
| Q3 FY2024 | Sep 30, 2024 | -5392.7% | −5229.1 |
| Q2 FY2024 | Jun 30, 2024 | -7998.8% | −7835.4 |
| Q4 FY2023 | Dec 31, 2023 | -1751.6% | −1704.5 |
| Q3 FY2023 | Sep 30, 2023 | -194.2% | −183.5 |
| Q2 FY2023 | Jun 30, 2023 | -163.6% | −130.0 |
| Q1 FY2023 | Mar 31, 2023 | -163.4% | −133.5 |
| Q4 FY2022 | Dec 31, 2022 | -47.1% | −14.3 |
| Q3 FY2022 | Sep 30, 2022 | -10.6% | +40.2 |
| Q2 FY2022 | Jun 30, 2022 | -33.6% | +101.7 |
| Q1 FY2022 | Mar 31, 2022 | -29.9% | −8.8 |
| Q4 FY2021 | Dec 31, 2021 | -32.8% | +82.8 |
| Q3 FY2021 | Sep 30, 2021 | -50.8% | −53.1 |
| Q2 FY2021 | Jun 30, 2021 | -135.4% | −127.2 |
| Q1 FY2021 | Mar 31, 2021 | -21.1% | −29.6 |
| Q4 FY2020 | Dec 31, 2020 | -115.6% | −94.5 |
| Q3 FY2020 | Sep 30, 2020 | 2.3% | −5.4 |
| Q2 FY2020 | Jun 30, 2020 | -8.1% | −15.0 |
| Q1 FY2020 | Mar 31, 2020 | 8.5% | −2.8 |
| Q4 FY2019 | Dec 31, 2019 | -21.1% | +2.9 |
| Q3 FY2019 | Sep 30, 2019 | 7.7% | −3.1 |
| Q2 FY2019 | Jun 30, 2019 | 6.9% | +3.2 |
| Q1 FY2019 | Mar 31, 2019 | 11.4% | −0.2 |
| Q4 FY2018 | Dec 31, 2018 | -23.9% | −44.2 |
| Q3 FY2018 | Sep 30, 2018 | 10.8% | −1.3 |
| Q2 FY2018 | Jun 30, 2018 | 3.8% | −3.2 |
| Q1 FY2018 | Mar 31, 2018 | 11.6% | −7.4 |
| Q4 FY2017 | Dec 31, 2017 | 20.3% | +28.8 |
| Q3 FY2017 | Sep 30, 2017 | 12.2% | +52.3 |
| Q2 FY2017 | Jun 30, 2017 | 6.9% | – |
| Q1 FY2017 | Mar 31, 2017 | 19.0% | – |
| Q4 FY2016 | Dec 31, 2016 | -8.5% | – |
| Q3 FY2016 | Sep 30, 2016 | -40.1% | – |
See a number that looks wrong?